Pharma Focus America

News

Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area

EicOsis has Initiated a Phase 1B Clinical Trial For EC5026

Wednesday, January 31, 2024

EicOsis Human Health a pharmaceutical company specializing in nonnarcotic oral analgesics targeting the soluble epoxide hydrolase enzyme has recently announced the initiation of its Phase b multipleascending dose clinical trial for the drug candidate...

Vect-horus and Ionis Pharmaceuticals Have Entered an Exclusive License Agreement to Advance the Systemic Delivery of RNA-targeted Medicines for Neurological Diseases

Wednesday, January 31, 2024

VectHorus a privately owned biotech firm specializing in the development of molecular vectors for targeted therapeutic and imaging agent delivery has recently disclosed a global licensing agreement with Ionis Pharmaceuticals Inc

Avenacy Introduces Bivalirudin for Injection to the U.S. Market

Tuesday, January 30, 2024

Avenacy a specialized pharmaceutical company focused on providing essential injectable medications has announced the launch of Bivalirudin for Injection in the United States This medication is a therapeutic equivalent generic for Angiomax for Injecti...

Ractigen Therapeutics and University Medical Center Utrecht Establish Strategic Collaboration to Advance saRNA Innovation in Neurodevelopmental Disorders

Monday, January 29, 2024

Ractigen Therapeutics a clinicalstage pharmaceutical company specializing in small activating RNA therapeutics has formally announced a collaboration with the University Medical Center Utrecht affiliated with Utrecht University

MitoSense Inc. and Uppsala University Achieve Breakthrough in Mitochondrial Preservation with Elliott Mitochondrial Center and Sallie Astor Burdine Breast Foundation

Friday, January 26, 2024

MitoSense Inc a leading biotechnology innovator focusing on neurodegenerative diseases has announced a significant scientific breakthrough in collaboration with Uppsala University the Elliott Mitochondrial Center

TransCelerate BioPharma: Facilitating Growth and Encouraging Innovation and Collaboration within the Biopharmaceutical Research and Development Community

Thursday, January 25, 2024

TransCelerate BioPharma Inc announced today an expansion of its membership and the appointment of the organizations Chief Operating Officer Gilead Sciences Inc a leading biopharmaceutical company

VGXI and Resilience Establish Long-Term Partnership to Accelerate Biomanufacturing of Advanced Therapeutics

Thursday, January 25, 2024

VGXI Inc a prominent contract developer and manufacturer specializing in nucleic acid biopharmaceuticals such as gene therapies DNA vaccines and RNA medicines has recently announced a strategic multiyear partnership

IAMA Therapeutics Commences Phase 1 Clinical Trial for IAMA-6 in Autism and Epilepsy Treatment, Marking First Subject Dosage

Wednesday, January 24, 2024

IAMA Therapeutics a pharmaceutical company dedicated to advancing medicines for children affected by brain disorders has announced the initiation of the firstinhuman trial for IAMA This orally administered small molecule therapeutic targets NKCC

CDR-life Announces FDA Clearance of the Investigational New Drug (IND) Application for CDR404 for the Treatment of Solid Tumors

Wednesday, January 24, 2024

CDRLife Inc made an announcement today regarding the clearance of its Investigational New Drug application by the US Food and Drug Administration for CDR This is a noteworthy development for CDR

Recipharm, Medspray, and Resyca Enter Into Exclusive License Agreement to Develop Nasally-delivered Drug Products Using Proprietary Soft Mist Technology

Wednesday, January 24, 2024

Recipharm a leading contract development and manufacturing organisation is pleased to announce an exclusive licence and collaboration agreement with Medspray and Resyca